These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7771637)

  • 1. Vasodilatory state of decompensated cirrhosis: relation to hepatic dysfunction, ascites, and vasoactive substances.
    Friedman HS; Cirillo N; Schiano F; Nathan P; Khan S; Rosero H; Vaseghi M; Sacchi T; Vasavada B; Bjornson L
    Alcohol Clin Exp Res; 1995 Feb; 19(1):123-9. PubMed ID: 7771637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascites as a marker for the hyperdynamic heart of Laennec's cirrhosis.
    Friedman HS; Fernando H
    Alcohol Clin Exp Res; 1992 Oct; 16(5):968-70. PubMed ID: 1443437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of a relation between urinary digoxin-like immunoreactive substance and cardiac performance.
    Friedman HS; Babb B; Shim IB; Sotomora G; Farrer SM; Vasavada BC
    Chest; 1993 Mar; 103(3):878-81. PubMed ID: 8449085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
    Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
    J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
    Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma glucagon concentration in cirrhosis is related to liver function but not to portal-systemic shunting, systemic vascular resistance, or urinary sodium excretion.
    Lewis FW; Adair O; Hossack KF; Everson GT; White JC; Rector WG
    J Lab Clin Med; 1991 Jan; 117(1):67-75. PubMed ID: 1987311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doppler ultrasound of hepatic and system hemodynamics in patients with alcoholic liver cirrhosis.
    Zekanovic D; Ljubicic N; Boban M; Nikolic M; Delic-Brkljacic D; Gacina P; Klarin I; Turcinov J
    Dig Dis Sci; 2010 Feb; 55(2):458-66. PubMed ID: 19277866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous glycosides in critically ill patients.
    Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
    Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt.
    Huonker M; Schumacher YO; Ochs A; Sorichter S; Keul J; Rössle M
    Gut; 1999 May; 44(5):743-8. PubMed ID: 10205217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis.
    Lewis FW; Adair O; Rector WG
    Gastroenterology; 1992 Mar; 102(3):1024-9. PubMed ID: 1537494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the hemodynamics between patients with alcoholic or HCV-related cirrhosis.
    Momiyama K; Nagai H; Sumino Y
    Hepatogastroenterology; 2011; 58(112):2036-40. PubMed ID: 22234075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose.
    Yang SS; Hughes RD; Williams R
    Hepatology; 1988; 8(1):93-7. PubMed ID: 2828215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericardial effusion and left ventricular dysfunction associated with ascites secondary to hepatic cirrhosis.
    Shah A; Variyam E
    Arch Intern Med; 1988 Mar; 148(3):585-8. PubMed ID: 3341860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of ascites on splanchnic and systemic hemodynamics in patients with alcoholic cirrhosis].
    Cereda JM; Braillon A; Ozier Y; Moreau R; Gaudin C; Lebrec D
    Gastroenterol Clin Biol; 1989 May; 13(5):495-8. PubMed ID: 2753286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler hemodynamic study in portal hypertension and hepatic encephalopathy.
    Perisic M; Ilic-Mostic T; Stojkovic M; Culafic D; Sarenac R
    Hepatogastroenterology; 2005; 52(61):156-60. PubMed ID: 15783018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of cardiac function in cirrhotic patients with and without ascites.
    Valeriano V; Funaro S; Lionetti R; Riggio O; Pulcinelli G; Fiore P; Masini A; De Castro S; Merli M
    Am J Gastroenterol; 2000 Nov; 95(11):3200-5. PubMed ID: 11095342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial.
    Kimer N; Pedersen JS; Busk TM; Gluud LL; Hobolth L; Krag A; Møller S; Bendtsen F;
    Hepatology; 2017 Feb; 65(2):592-603. PubMed ID: 27775818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic impact of tension ascites and evacuatory paracentesis].
    Martínez Odriozola P; Miguel de la Villa F; Solano López D; de las Heras B; Franco Vicario R; Bilbao Goitia P; García Jiménez N; Muñoz Sánchez J
    Rev Clin Esp; 1992 Oct; 191(5):245-51. PubMed ID: 1475438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary digoxin-like immunoreactive substance in pregnancy. Relation to urinary electrolytes.
    Friedman HS; Abramowitz I; Nguyen T; Babb B; Stern M; Farrer SM; Tricomi V
    Am J Med; 1987 Aug; 83(2):261-4. PubMed ID: 3618628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.